Second Balkan Conference on Personalized Medicine: Preliminary Program

personalised medicine

Second Balkan Conference on Personalized Medicine: Preliminary Program

Second Balkan Conference on Personalized Medicine


October 24th-25th, 2019, “Opal”Hall, Hotel “Ramada”, Sofia

Organized by the Bulgarian Alliance for Precision and Personalized Medicine – BAPPM

In collaboration with the European Alliance for Personalised Medicine – EAPM, Medical University Pleven and Bulgarian Society of Human Genetics and Genomics


Preliminary Program

Thursday, October 24th, 2019

13.30 – 14.00 Registration

14.00 – 14.30 Opening: Setting the Scene

14.30 – 16.00 First Plenary Session: Forward Together in the   Personalised Medicine Era

Personalized Medicine – What will be covered in this opening session is the broad impact of the personalized medicine, which promises to create a new paradigm in healthcare.

The key is to find the optimum ways by which to integration personalized medicine into the EU’s healthcare systems, facilitate, the introduction of innovative pharmaceuticals and diagnostics, and build the necessary legal and regulatory frames.

In addition, there is a need to formulate optimal HTA of personalized medicine products, and, of course, bring about the best pathways to dramatically improve patient access to innovative treatments

16.00 – 17.30 Second Plenary Session:  Genomics for Healthcare

This session will look at new achievements in human genomics and genetics alongside gene therapy and the European Genomic Initiative “1+MG”.

With rising healthcare costs and systems being increasingly challenged, genomics has the potential to impact the health of all of us and provide diagnostic, economic and efficiency benefits, ensuring a patient has the right information, to get the right treatment, at the right time.

The potential for bettering the health of citizens across all Member States is huge.

If fully realized genomics will have a positive impact on the health of all of us by giving diagnostic, economic and efficiency benefits by ensuring the right patient, gets the right diagnosis and treatment, at the right time. Also hugely important for healthcare (and fiscal) reasons is the preventative sector which involves screening and early diagnosis, while the session will also include the important areas of rare diseases, oncology and neurological diseases.

Precision diagnostics are vital today, so we will look at NGS in preventive medicine and clinical practice. Comprehensive genomic profiling will also be discussed.

On top of this, the growing area of AI in personalized medicine cannot be denied, but implementing it is a key. Here we look at the current status and future possibilities.

17.30 – 17.50 Coffee-break

17.50 – 19.20 Third Plenary Session:  The pathology of Personalised Medicine

Molecular pathology – specifically new achievements and implementation in clinical practice.

Precision imaging in modern-day healthcare.

19.30 – 22.00 Official Dinner and announcement of the winners of BAPPM Awards for Personalized Medicine in Bulgaria


Friday, October 25th, 2019

09.00 – 09.30 Registration and Morning Coffee

09.30 – 11.30 Fourth Plenary Session: Personalized medicine in oncology and hematology.

This session will cover screening, targeted and combined therapy, as well as adjuvant and neoadjuvant therapy.

Also covered will be immunotherapy, radiotherapy, the monitoring of lung cancer, as well as colon cancer, prostate cancer, melanoma, pancreatic cancer, and head and neck cancer.

Personalised medicine in hematology

However, as always, we should be aware of the economic impacts (good and bad) of precision medicine. An outstanding high cost will not be sustainable in the long term, so development of technologies for cost reduction should not be ignored

11.30 – 13.00 Fifth Plenary Session: Personalized medicine and rare diseases and personalized medicine in endocrinology

Personalised medicine in rare diseases

Personalised medicine in endocrinology

Some of the bottlenecks for precision medicine include the cost, as well as privacy concerns. These designer drugs are usually only effective for a small cohort of patients, so to recover costs put into developing the drug, a pharmaceutical company may charge much higher prices than for other medicines.

Also, like other health data, genetic information is private information, so security must be maintained for all patients.

13.00 – 14.00 Working Lunch

14.00 – 15.30 Sixth Plenary Session: Personalized medicine and virus infections, and personalized medicine in neurology and psychiatry

For neurological diseases there is a need for comprehensive genetic assessment, classification, biomarkers, and treatments specified to a person’s molecular drivers.

This session will cover these topics and more.

15.00 – 16.30 Eighth Plenary Session:  Cooperation & Balkan Framework

No Member State can go it alone when it comes to modern-day healthcare, despite the closely guarded national competence in this large arena.

Cross-border collaboration is vital now and will be even more so going forward, and the innovative work of regions must also be harnessed and, crucially, shared.

This final session will seek to establish the need for cooperation and seek a unity that such cooperations are necessary as we strive to make personalised medicine the norm, and deliver the right treatment to the right patient at the right time.

16.30 – 17.30 Poster Session

17.30 – 18.00 Closing


Application for poster sessions:

Official languages: Bulgarian and English

Share this post

Leave a Reply

Your email address will not be published. Required fields are marked *